{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:18:29Z","timestamp":1777954709334,"version":"3.51.4"},"reference-count":22,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pain Practice"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<jats:bold>s<\/jats:bold><\/jats:title><jats:p>A post\u2010marketing surveillance was conducted to evaluate the safety and efficacy of the buprenorphine transdermal patch under actual clinical practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 3017 patients included in the safety analysis, adverse drug reactions (ADRs) were observed in 1524 (50.5%), the most common being nausea, skin symptoms at the site of application, constipation, and vomiting. The incidences of respiratory depression and withdrawal symptoms were low, and no drug dependence was observed. Among the 2573 patients included in the efficacy analysis, the efficacy (\u22652\u2010point improvement in the numerical rating scale) rate was 74.4%, which was significantly higher in older adults (\u226565 y.o) than in younger adults. Discontinuation was mostly caused by ADRs during the early initiation phase.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study demonstrated the safety and efficacy of long\u2010term administration of buprenorphine transdermal patches, suggesting that pain control is possible over the long term if attention is paid to ADRs in the early stages of administration.<\/jats:p><\/jats:sec>","DOI":"10.1111\/papr.13430","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T06:28:48Z","timestamp":1729578528000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety and efficacy of long\u2010term use of a buprenorphine transdermal patch system in patients with osteoarthritis and low back pain refractory to non\u2010opioid analgesics: Post\u2010marketing surveillance of 3000 cases"],"prefix":"10.1111","volume":"25","author":[{"given":"Takahiro","family":"Ushida","sequence":"first","affiliation":[{"name":"Aichi Medical University  Nagakute\u2010shi Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumiko","family":"Kanzaki","sequence":"additional","affiliation":[{"name":"Scientific Affairs Division Mundipharma K.K.  Minato\u2010ku, Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5997-3404","authenticated-orcid":false,"given":"Keishi","family":"Katayama","sequence":"additional","affiliation":[{"name":"Scientific Affairs Division Mundipharma K.K.  Minato\u2010ku, Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akito","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Scientific Affairs Division Mundipharma K.K.  Minato\u2010ku, Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"e_1_2_12_2_1","volume-title":"Clinical practice guidelines for the management of chronic pain","author":"Working Group for the Development of Clinical Practice Guidelines for the Management of Chronic Pain","year":"2021"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00776-011-0102-y"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00776-015-0730-8"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129262"},{"key":"e_1_2_12_6_1","unstructured":"Japan Society of Pain Clinicians.Guidelines for Prescribing Opioid Analgesics for Chronic Non\u2010cancer pain. Japanese.https:\/\/www.jspc.gr.jp\/Contents\/public\/kaiin_guideline04.html"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.051528"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.09.019"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2010.00271.x"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.2169\/naika.106.75"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/ael051"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2010.00378.x"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S38562"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1320-8"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2008.00204.x"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1091975"},{"key":"e_1_2_12_17_1","first-page":"1254","article-title":"Sex\u2010based differences in drug activity","volume":"80","author":"Whitley H","year":"2009","journal-title":"Am Fam Physician"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aet127"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g6380"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.4055\/cios.2016.8.4.465"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0953-z"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1734-1140(11)70609-0"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S3919"}],"container-title":["Pain Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/papr.13430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T13:30:08Z","timestamp":1737034208000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/papr.13430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1111\/papr.13430"],"URL":"https:\/\/doi.org\/10.1111\/papr.13430","archive":["Portico"],"relation":{},"ISSN":["1530-7085","1533-2500"],"issn-type":[{"value":"1530-7085","type":"print"},{"value":"1533-2500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"2024-10-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e13430"}}